+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Choroidal Neovascularization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

  • ID: 5181500
  • Report
  • October 2020
  • Region: Global
  • 142 pages
  • IMARC Group

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bayer AG
  • Gilead Sciences Inc.
  • Hoffmann-La Roche Ltd.
  • MaaT Pharma
  • Novartis AG
  • Pfizer Inc.
  • MORE
The global choroidal neovascularization market grew at a CAGR of around 8% during 2014-2019. Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.

The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market. However, with the spread of the coronavirus disease (COVID-19), the healthcare systems of various countries have become overburdened. Consequently, doctors are focusing on patient selection, safe injection techniques and proper sterilization to prevent the risk of contracting and transmitting the disease. In a non-emergency case, they are either rescheduling and postponing the follow-up appointments or providing remote monitoring solutions using telehealth to patients with severe conditions. Looking forward, the publisher expects the global choroidal neovascularization market to exhibit moderate growth during the next five years.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global choroidal neovascularization market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, product type, type of diagnosis, treatment type and application.

Breakup by Product Type:
  • Intravenous
  • Intravitreal
Breakup by Type of Diagnosis:

Fluorescein Angiography (FA)
  • Indocyanine Green (ICG) Angiography
Spectral Domain Optical Coherence Tomography (OCT)
  • Others
Breakup by Treatment Type:
  • Angiogenesis Inhibitors Injection
  • Photodynamic Therapy
  • Laser photocoagulation
  • Low-dose Radiation Therapy
  • Surgery
Breakup by Application:
  • Extreme Myopia
  • Malignant Myopic Degeneration
  • Age-Related Developments
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., Hoffmann-La Roche Ltd., MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).

Key Questions Answered in This Report:
  • How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global choroidal neovascularization market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the type of diagnosis?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global choroidal neovascularization market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Gilead Sciences Inc.
  • Hoffmann-La Roche Ltd.
  • MaaT Pharma
  • Novartis AG
  • Pfizer Inc.
  • MORE
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Choroidal Neovascularization Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type
6.1 Intravenous
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intravitreal
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Type of Diagnosis
7.1 Fluorescein Angiography (FA)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Indocyanine Green (ICG) Angiography
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Spectral Domain Optical Coherence Tomography (OCT)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast

8 Market Breakup by Treatment Type
8.1 Angiogenesis Inhibitors Injection
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Photodynamic Therapy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Laser Photocoagulation
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Low-dose Radiation Therapy
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Surgery
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Application
9.1 Extreme Myopia
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Malignant Myopic Degeneration
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Age-Related Developments
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast

11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bausch Health Companies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Bayer AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Gilead Sciences, Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.5 MaaT Pharma
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Novartis AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Pfizer Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Regeneron Pharmaceuticals Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio

List of Figures
Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014-2019
Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2019
Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2019
Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2019
Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2019
Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2019
Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million US$), 2014 & 2019
Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million US$), 2014 & 2019
Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million US$), 2014 & 2019
Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million US$), 2014 & 2019
Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million US$), 2014 & 2019
Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million US$), 2014 & 2019
Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million US$), 2014 & 2019
Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million US$), 2014 & 2019
Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million US$), 2014 & 2019
Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million US$), 2014 & 2019
Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million US$), 2014 & 2019
Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million US$), 2014 & 2019
Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million US$), 2014 & 2019
Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million US$), 2014 & 2019
Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million US$), 2014 & 2019
Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
Figure 87: Global: Choroidal Neovascularization Industry: Porter’s Five Forces Analysis

List of Tables
Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million US$), 2020-2025
Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million US$), 2020-2025
Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million US$), 2020-2025
Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million US$), 2020-2025
Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 7: Global: Choroidal Neovascularization Market Structure
Table 8: Global: Choroidal Neovascularization Market: Key Players
Note: Product cover images may vary from those shown
  • Bausch Health Companies Inc.
  • Bayer AG
  • Gilead Sciences Inc.
  • Hoffmann-La Roche Ltd.
  • MaaT Pharma
  • Novartis AG
  • Pfizer Inc.
  • Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited)
  • Regeneron Pharmaceuticals Inc.
  • Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll